journal article·2022-03

Single‐Cell RNA Sequencing Reveals the Temporal Diversity and Dynamics of Cardiac Immunity after Myocardial Infarction

Kaiyu Jin, Shan Gao, Penghui Yang, Rongfang Guo, Dan Li, Yunsha Zhang, Xiaoyan Lu, Guanwei Fan, Xiaohui Fan

Small Methods· Volume 6· Issue 3
Publisher page

Abstract

Abstract Myocardial infarction (MI) is strongly associated with the temporal regulation of cardiac immunity. However, a variety of current clinical trials have failed because of the lack of post‐MI immunomodulating/anti‐inflammatory targets. Single‐cell RNA sequencing analysis of the cardiac Cd45 + immune cell at 0, 3, 7, and 14 d after injury in a mouse left anterior descending coronary artery ligation model is performed. Major immune cell populations, distinct subsets, and dynamic changes are identified. Macrophages (Mø) are most abundant, peaking at 3 d after infarction. Mø‐5 and Mø‐6 are the predominant infiltrated subsets at this time point, with strong expression of inflammatory factors. Further analysis demonstrates that suppressing these sets attenuated pathological MI progression by preventing subsequent leukocyte extravasation and adverse remodeling. Abundant apoptotic neutrophils and a profibrotic macrophage subset on days 7 and 14, respectively, are also detected. These results provide a basis for developing cell type‐ and time‐specific interventions in MI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cardiac Fibrosis and Remodeling · Atherosclerosis and Cardiovascular Diseases · Single-cell and spatial transcriptomics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pharmaceutical Informatics Institute College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 China

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin Key Laboratory of Translational Research of TCM Prescription and Syndrome Tianjin 300193 China

National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Tianjin 300193 China

School of Integrative Medicine Tianjin University of Traditional Chinese Medicine Tianjin 300193 China

State Key Laboratory of Component‐Based Chinese Medicine Tianjin 301617 China

Westlake Laboratory of Life Sciences and Biomedicine Hangzhou 310058 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (62)

Show source-provided references
1. 10.1161/CIRCULATIONAHA.117.03079810.1161/CIRCULATIONAHA.117.030798 ↗
2. 10.1161/CIRCRESAHA.111.24316210.1161/CIRCRESAHA.111.243162 ↗
3. 10.1093/cvr/cvy14510.1093/cvr/cvy145 ↗
4. 10.1038/s41577-018-0065-810.1038/s41577-018-0065-8 ↗
5. 10.1007/s00395-019-0769-310.1007/s00395-019-0769-3 ↗
6. 10.1161/CIRCRESAHA.115.30356710.1161/CIRCRESAHA.115.303567 ↗
7. 10.1038/s41590-018-0272-210.1038/s41590-018-0272-2 ↗
8. 10.1161/CIRCRESAHA.120.31720010.1161/CIRCRESAHA.120.317200 ↗
9. 10.7554/eLife.4388210.7554/eLife.43882 ↗
10. 10.1161/CIRCRESAHA.116.30407210.1161/CIRCRESAHA.116.304072 ↗
11. 10.1084/jem.2019236210.1084/jem.20192362 ↗
12. 10.1161/CIRCRESAHA.118.31402810.1161/CIRCRESAHA.118.314028 ↗
13. 10.1016/j.immuni.2013.11.01910.1016/j.immuni.2013.11.019 ↗
14. 10.1182/blood-2012-01-40739510.1182/blood-2012-01-407395 ↗
15. 10.1016/j.abb.2014.09.00510.1016/j.abb.2014.09.005 ↗
16. 10.1038/s41591-019-0590-410.1038/s41591-019-0590-4 ↗
17. 10.1038/s41467-020-20059-610.1038/s41467-020-20059-6 ↗
18. 10.1093/cvr/cvaa10110.1093/cvr/cvaa101 ↗
19. 10.1161/CIRCRESAHA.117.31093310.1161/CIRCRESAHA.117.310933 ↗
20. 10.1002/path.539210.1002/path.5392 ↗
21. 10.1016/j.imbio.2017.05.01110.1016/j.imbio.2017.05.011 ↗
22. 10.3390/ijms1903087810.3390/ijms19030878 ↗
23. 10.1038/sj.onc.120681610.1038/sj.onc.1206816 ↗
24. 10.3389/fimmu.2019.0303110.3389/fimmu.2019.03031 ↗
25. 10.1152/ajpgi.00544.201110.1152/ajpgi.00544.2011 ↗
26. 10.4049/jimmunol.180.8.570710.4049/jimmunol.180.8.5707 ↗
27. 10.1016/j.jacc.2019.10.03610.1016/j.jacc.2019.10.036 ↗
28. 10.1016/j.trsl.2016.04.00610.1016/j.trsl.2016.04.006 ↗
29. 10.1093/cvr/cvy21110.1093/cvr/cvy211 ↗
30. 10.1038/nm.328410.1038/nm.3284 ↗
31. 10.1253/circj.69.148410.1253/circj.69.1484 ↗
32. 10.1161/CIRCULATIONAHA.118.03504710.1161/CIRCULATIONAHA.118.035047 ↗
33. 10.1073/pnas.111658410910.1073/pnas.1116584109 ↗
34. 10.1016/j.ijcard.2016.06.30910.1016/j.ijcard.2016.06.309 ↗
35. 10.1038/s41590-020-0736-z10.1038/s41590-020-0736-z ↗
36. 10.1126/science.119921410.1126/science.1199214 ↗
37. 10.1096/fj.201901265R10.1096/fj.201901265R ↗
38. 10.1182/blood-2005-01-01508110.1182/blood-2005-01-015081 ↗
39. 10.1016/S0002-9440(10)63596-110.1016/S0002-9440(10)63596-1 ↗
40. 10.1016/j.immuni.2014.03.01310.1016/j.immuni.2014.03.013 ↗
41. 10.1038/s41423-020-0504-x10.1038/s41423-020-0504-x ↗
42. 10.1161/CIRCULATIONAHA.119.04169410.1161/CIRCULATIONAHA.119.041694 ↗
43. 10.1016/j.immuni.2018.08.01210.1016/j.immuni.2018.08.012 ↗
44. 10.1073/pnas.121806111010.1073/pnas.1218061110 ↗
45. 10.1016/j.phrs.2020.10536410.1016/j.phrs.2020.105364 ↗
46. 10.1038/s41590-018-0276-y10.1038/s41590-018-0276-y ↗
47. 10.1038/s42256-020-00233-710.1038/s42256-020-00233-7 ↗
48. 10.1093/cvr/cvz22110.1093/cvr/cvz221 ↗
49. 10.1146/annurev-physiol-022516-03433910.1146/annurev-physiol-022516-034339 ↗
50. 10.1038/s41467-018-06318-710.1038/s41467-018-06318-7 ↗
51. 10.1172/JCI12337410.1172/JCI123374 ↗
52. 10.1161/CIRCRESAHA.117.31132610.1161/CIRCRESAHA.117.311326 ↗
53. 10.1160/th14-02-013910.1160/th14-02-0139 ↗
54. 10.1007/s00395-020-0789-z10.1007/s00395-020-0789-z ↗
55. 10.1038/nbt.409610.1038/nbt.4096 ↗
56. 10.1038/nmeth.440210.1038/nmeth.4402 ↗
57. 10.1038/s41586-019-0969-x10.1038/s41586-019-0969-x ↗
58. 10.1093/bioinformatics/btw82110.1093/bioinformatics/btw821 ↗
59. 10.1038/s41586-018-0698-610.1038/s41586-018-0698-6 ↗
60. 10.1089/omi.2011.011810.1089/omi.2011.0118 ↗
61. 10.1016/j.neuron.2017.09.02610.1016/j.neuron.2017.09.026 ↗
62. Wu L. · J. Evidence‐Based Complementary Altern. Med. · 2013 · 2013 · 915343